Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human JAM-A Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB1103
This item is not returnable.
View return policy
Description
JAM-A Monoclonal specifically detects JAM-A in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF-ready.Specifications
JAM-A | |
Monoclonal | |
LYOPH | |
Flow Cytometry 0.25 ug/10^6 cells, Immunohistochemistry 8-25 ug/mL, Immunocytochemistry 8-25 ug/mL, CyTOF-ready | |
Q9Y624 | |
F11R | |
Mouse myeloma cell line NS0-derived recombinant human JAM-A Ser28-Ala242 (predicted) Accession # Q9Y624 | |
100 μg | |
Primary | |
Detects human JAM-A in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) JAM-B, recombinant mouse (rm) JAM-A, or rmJAM-4 is observed. | |
Human | |
Purified |
Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF | |
654806 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CD321, CD321 antigen, F11 receptor, F11R, JAM-1, JAM1CD321, JAMA, JAM-A, JCAMJAM, Junctional adhesion molecule 1Platelet F11 receptor, junctional adhesion molecule A, PAM-1, PAM-1KAT, Platelet adhesion molecule 1 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
50848 | |
Sterile PBS to a final concentration of 0.5 mg/mL. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction